Tumor suppressor p16INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model

FEBS Journal

Volumn 277, Issue 17, 2010, Pages 3552-3563

  Sanchez Ruderisch, Hugo ^a   Fischer, Christian ^a   Detjen, Katharina M ^a   Welzel, Martina ^a   Wimmel, Anja ^a   Manning, Joachim C ^b   André, Sabine ^b   Gabius, Hans Joachim ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

anoikis; galectin; glycosylation; integrin; pancreatic carcinoma

Indexed keywords

CASPASE 8; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GALECTIN 1; GALECTIN 3; MESSENGER RNA;

ANOIKIS; ARTICLE; CANCER MODEL; CELL ACTIVITY; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NORTHERN BLOTTING; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEADY STATE; UPREGULATION; BIOLOGICAL MODEL; METABOLISM; PANCREAS TUMOR; TUMOR CELL CULTURE;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; GALECTIN 1; GALECTIN 3; HUMANS; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77955778590     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07764.x     Document Type: Article

References (58)

1. Sherr CJ (2001) The INK4aARF network in tumour suppression. Nat Rev Mol Cell Biol 2, 731 737.
2. Kim WY Sharpless NE (2006) The regulation of INK4ARF in cancer and aging. Cell 127, 265 275.
3. 51 fibronectin receptor. J Cell Biol 150, 1467 1478.
4. 1 analyzed by a three-dimensional mapping technique. Eur J Biochem 237, 76 85.
5. Sharon N Lis H (1997) Glycoproteins: structure and function. In Glycosciences: Status and Perspectives (Gabius H-J Gabius S eds pp 133 162. Chapman & Hall
6. Reuter G Gabius H-J (1999) Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell Mol Life Sci 55, 368 422.
7. 1 integrins. Biochim Biophys Acta 1663, 52 60.
8. Honke K Taniguchi N (2009) Animal models to delineate glycan functionality. In The Sugar Code. Fundamentals of Glycosciences (Gabius H-J ed pp 385 401. Wiley-VCH
9. INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 274, 3233 3256.
10. Reuter G Gabius H-J (1996) Sialic acids: structure-analysis-metabolism- occurrence-recognition. Biol Chem Hoppe Seyler 377, 325 342.
11. Patsos G Corfield A (2009) O-Glycosylation: structural diversity and functions. In The Sugar Code. Fundamentals of Glycosciences (Gabius H-J ed pp 111 137. Wiley-VCH
12. Zuber C Roth J (2009) N-Glycosylation. In The Sugar Code. Fundamentals of Glycosciences (Gabius H-J ed pp. 87 110. Wiley-VCH
13. Gabius H-J (2006) Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit Rev Immunol 26, 43 79.
14. Villalobo A, Nogales-González A Gabius H-J (2006) A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol 18, 1 37.
15. Gabius H-J, ed. (2009) The Sugar Code. Fundamentals of Glycosciences. Weinheim: Wiley-VCH
16. Ahmad N, Gabius H-J, Kaltner H, André S, Kuwabara I, Liu F-T, Oscarson S, Norberg T Brewer CF (2002) Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3, and -7: evidence for differential binding specificities. Can J Chem 80, 1096 1104.
17. Wu AM, Singh T, Wu JH, Lensch M, André S Gabius H-J (2006) Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. Glycobiology 16, 524 537.
18. André S, Sansone F, Kaltner H, Casnati A, Kopitz J, Gabius H-J Ungaro R (2008) Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactoselactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesiongrowth-regulatory galectins. ChemBioChem 9, 1649 1661.
19. André S, Koár T, Kojima S, Unverzagt C Gabius H-J (2009) From structural to functional glycomics: core substitutions as molecular switches for shape and lectin affinity of N-glycans. Biol Chem 390, 557 565.
20. Lahm H, André S, Hoeflich A, Kaltner H, Siebert H-C, Sordat B, von der Lieth C-W, Wolf E Gabius H-J (2004) Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J 20, 227 238.
21. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M Gabius H-J (2001) Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 276, 35917 35923.
22. André S, Kaltner H, Lensch M, Russwurm R, Siebert H-C, Fallsehr C, Tajkhorshid E, Heck AJR, von Knebel Doeberitz M, Gabius H-J et al. (2005) Determination of structural and functional overlapdivergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells. Int J Cancer 114, 46 57.
23. Elad-Sfadia G, Haklai R, Balan E Kloog Y (2004) Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 279, 34922 34930.
24. Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ Marshall MS (1999) Lack of elevated MAP kinase (ERK) activity in pancreatic carcinomas despite oncogenic K-Ras expression. Int J Oncol 15, 271 279.
25. Kim H-R, Lin H-M, Biliran H Raz A (1999) Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 59, 4148 4154.
26. Schaffert C, Pour PM Chaney WG (1998) Localization of galectin-3 in normal and diseased pancreatic tissue. Int J Pancreatol 23, 1 9.
27. 51 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 280, 37266 37277.
28. André S, Kopitz J, Kaltner H, Villalobo A Gabius H-J (2009) Glycans as functional markers in malignancy? In The Sugar Code. Fundamentals of Glycosciences (Gabius H-J ed pp 419 432. Wiley-VCH
29. Smetana K Jr., Dvoánková B, Chovanec M, Bouek J, Klíma J, Motlík J, Lensch M, Kaltner H, André S Gabius H-J (2006) Nuclear presence of adhesiongrowth-regulatory galectins in normalmalignant cells of squamous epithelial origin. Histochem Cell Biol 125, 171 182.
30. Ahmad N, Gabius H-J, André S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F Brewer CF (2004) Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 279, 10841 10847.
31. Wang J, Lu ZH, Gabius H-J, Rohowsky-Kochan C, Ledeen RW Wu G (2009) Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 182, 4036 4045.
32. Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E Gabius H-J (2001) Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127, 375 386.
33. Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P et al. (2007) Gene-expression signature of adhesiongrowth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 51, 681 690.
34. Cludts S, Decaestecker C, Mahillon V, Chevalier D, Kaltner H, André S, Remmelink M, Leroy X, Gabius H-J Saussez S (2009) Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectins-1, -3 and -7. Anticancer Res 29, 4933 4940.
35. Polyak K, Xia Y, Zweier JL, Kinzler KW Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389, 300 305.
36. Bernerd F, Sarasin A Magnaldo T (1999) Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 96, 11329 11334.
37. Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, Hsu DK Liu F-T (2002) Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 277, 3487 3497.
38. Kopitz J, André S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu F-T, Cantz M et al. (2003) Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22, 6277 6288.
39. Sturm A, Lensch M, André S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU Gabius H-J (2004) Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 173, 3825 3837.
40. Patsos G, André S, Roeckel N, Gromes R, Gebert J, Kopitz J Gabius H-J (2009) Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 19, 726 734.
41. Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A Lemoine NR (2002) Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 160, 1745 1754.
42. Grützmann R, Pilarsky C, Ammerpohl O, Lüttges J, Böhme A, Sipos B, Foerder M, Alldinger I, Jahnke B, Schackert HK et al. (2004) Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6, 611 622.
43. Lu Z, Hu L, Evers S, Chen J Shen Y (2004) Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue. Proteomics 4, 3975 3988.
44. Pogue-Geile KL, Mackey JA, George RD, Wood PG, Lee KKW, Moser AJ, Tillman DL, Lyons-Weiler J Whitcomb DC (2004) A new microarray, enriched in pancreas and pancreatic cancer cDNAs to identify genes relevant to pancreatic cancer. Cancer Genomics Proteomics 1, 371 386.
45. Ide Y, Miyoshi E, Nakagawa T, Gu J, Tanemura M, Nishida T, Ito T, Yamamoto H, Kozutsumi Y Taniguchi N (2006) Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer. Biochem Biophys Res Commun 341, 478 482.
46. Berberat PO, Friess H, Wang L, Zhu Z, Bley T, Frigeri L, Zimmermann A Buchler MW (2001) Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem 49, 539 549.
47. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE et al. (2003) Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63, 8614 8622.
48. Shen J, Person MD, Zhu J, Abbruzzese JL Li D (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64, 9018 9026.
49. Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP et al. (2005) Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 129, 1187 1197.
50. Roda O, Ortiz-Zapater E, Martínez-Bosch N, Gutiérrez- Gallego R, Vila-Perelló M, Ampurdanés C, Gabius H-J, André S, Andreu D, Real FX et al. (2009) Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Gastroenterology 136, 1379 1390.
51. Gabius H-J, Engelhardt R, Rehm S Cramer F (1984) Biochemical characterization of endogenous carbohydrate-binding proteins from spontaneous murine rhabdomyosarcoma, mammary adenocarcinoma, and ovarian teratoma. J Natl Cancer Inst 73, 1349 1357.
52. André S, Pei Z, Siebert H-C, Ramström O Gabius H-J (2006) Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg Med Chem 14, 6314 6326.
53. Purkrabková T, Smetana K Jr., Dvoránková B, Holiková Z, Böck C, Lensch M, André S, Pytlík R, Liu F-T, Klíma J et al. (2003) New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol Cell 95, 535 545.
54. Kaltner H, Seyrek K, Heck A, Sinowatz F Gabius H-J (2002) Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts. Comparison of cell type-specific expression profiles and subcellular localization. Cell Tissue Res 307, 35 46.
55. Lohr M, Kaltner H, Lensch M, André S, Sinowatz F Gabius H-J (2008) Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresialuteolysis in contrast to pro-apoptotic galectins-1 and -7. Histochem Cell Biol 130, 567 581.
56. ada Z, Smetana K Jr., Lacina L, Plzáková Z, tork J, Kaltner H, Russwurm R, Lensch M, André S Gabius H-J (2009) Immunohistochemical fingerprinting of the network of seven adhesiongrowth-regulatory lectins in human skin and detection of distinct tumour-associated alterations. Folia Biol (Praha) 55, 145 152.
57. Szabo P, Dam TK, Smetana K Jr., Dvoránková B, Kübler D, Brewer CF Gabius H-J (2009) Phosphorylated human lectin galectin-3: analysis of ligand binding by histochemical monitoring of normalmalignant squamous epithelia and by isothermal titration calorimetry. Anat Histol Embryol 38, 68 75.
58. André S, Maljaars CEP, Halkes KM, Gabius H-J Kamerling JP (2007) Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. Bioorg Med Chem Lett 17, 793 798.